Our Team
Kurtuluş Berkay Gezen
He was born in Aydın in 1973. He has his Bsc degree from Middle East Technical University, Department of Electrical and Electronics Engineering . He worked in product management at Beko Elektronik for 6 years and took part in various international product development projects.
He continued his work in consumer electronics international trade activities between 2001-2007. Between 2008-2018, he served as the global commercial director of the brand CardiAid, the world's top automatic defibrillator brand, from its design to its spread in over 65 countries around the world. With his global experience, he provides strategic consultancy services to medical technology start-up companies in Turkey and India. He become the founder of fastest growing AED brand CardiAngel and operation in 15+ countries.
In 2018, he joined the founding team of tVNS Technologies as global sales director. As of December 2022, he continues to serve as CEO of tVNS Health GmbH, a Germany-based company established to manage the sales and operations of tVNS® devices worldwide , and continues to invest in medical technology to make vagus neuromodulation treatments accessible worldwide.
Kurtuluş Berkay Gezen
He was born in Aydın in 1973. He has his Bsc degree from Middle East Technical University, Department of Electrical and Electronics Engineering . He worked in product management at Beko Elektronik for 6 years and took part in various international product development projects.
He continued his work in consumer electronics international trade activities between 2001-2007. Between 2008-2018, he served as the global commercial director of the brand CardiAid, the world's top automatic defibrillator brand, from its design to its spread in over 65 countries around the world. With his global experience, he provides strategic consultancy services to medical technology start-up companies in Turkey and India. He become the founder of fastest growing AED brand CardiAngel and operation in 15+ countries.
In 2018, he joined the founding team of tVNS Technologies as global sales director. As of December 2022, he continues to serve as CEO of tVNS Health GmbH, a Germany-based company established to manage the sales and operations of tVNS® devices worldwide , and continues to invest in medical technology to make vagus neuromodulation treatments accessible worldwide.
Balu Ganapathy
He was born in 1975 in Bangalore, India. After completing his education in Total Quality Management and Business Administration at Bharathidasan University and working in various companies, he served as the quality director of the Opto Circuits group, which has a wide field of activity from America to Asia, for 11 years.
After working as regulatory director at Skanray Healthcare, he is responsible for managing the general operations of Meditix' Soultions, which he founded in 2018, with offices around the world and a consultant staff of 80 people. With 27 years of experience in the field of Regulatory Affairs and Quality Management system in the Medical Device Industry, he is Nervovita's partner responsible for Eastern Europe and Middle East regulatory operations. He has managed expert teams on FDA, CE MDR, ISO 13485 and ISO 14971 worldwide and has been responsible for successfully completing the regulatory processes of many medical devices around the world.
Senem Atay
Senem Erdoğan Atay was born in Izmir in 1982. In 2005, she graduated from Middle East Technical University, Department of Chemical Engineering. She started her career as North America Operations Officer at Maersk Shipping and continued as Product Manager at Deva İlaç.
He worked as Project Engineer at Bekaert, Boston Scientific Pacemakers Product Manager, and Customer Services Team Manager at Eczacıbaşı Building Products Group. He continued his career as Sales Manager at Enelsan.
In 2021, she joined the Nervovita Medical Technologies team as Marketing Manager and contributed to making tVNS treatment accessible and widespread in Turkey. As of July 2022, she continues to be the manager responsible for regulations and clinical studies at tVNS Health GmbH, managing global medical approval projects with the India-based clinical team.
Oguz Can Ergin
After completing his undergraduate education in Biomedical Engineering at Yeditepe University, he completed his master's degree in the same department. Since May 2024, he has been working on medical device technology, neuromodulation clinical research, international and patient device education and support in Türkiye. He speaks English fluently.
Eylül Doğa Hallac
She completed her associate degree in Audiometry at Şişli University. Since July 2024, she has been working on neuromodulation devices, university and hospital studies, device operations and Türkiye patient device training and support.
.jpeg)
Ahmed Alsharif
He graduated from Bahçeşehir University with a degree in Biomedical Engineering. He is fluent in both Arabic and English. Since October 2025, he has been working in the fields of neuromodulation technologies, clinical research, international patient training and support, as well as global technical assistance. In his current role, he is actively involved in patient support, device training, and user assistance.
Aylin Kesat
She graduated from Acıbadem University with a degree in Medical Engineering. Since November 2025, she has been working in the field of neuromodulation devices, taking responsibility for training processes and field support. Her areas of interest include neurostimulation technologies and clinical data monitoring. She has a good command of English.
Mariam Ismaeil
She graduated from Yıldız Technical University with a degree in Biomedical Engineering. Since November 2025, she has been working in the fields of medical device technology, neuromodulation devices, neuromodulation clinical research, patient training and support in Türkiye, as well as device operation processes. She has a good command of English and Arabic, and advanced proficiency in Turkish.
Merve Nur Akay
She completed her undergraduate studies in Biomedical Engineering at Ankara University. Since November 2025, she has been working in the field of neuromodulation devices and related clinical research. In this scope, she plays an active role in ensuring the proper use of devices in accordance with clinical protocols, improving patient experience, providing device training, and supporting field operations. She has a good command of English.
